{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:01:27Z","timestamp":1790362887712,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2003,3,1]]},"DOI":"10.1038\/sj.cgt.7700556","type":"journal-article","created":{"date-parts":[[2003,3,14]],"date-time":"2003-03-14T13:27:09Z","timestamp":1047648429000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme"],"prefix":"10.1038","volume":"10","author":[{"given":"Ettore","family":"Luzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Papucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Schiavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino","family":"Donnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lapucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Tempestini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Witort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Nicolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Capaccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,3,14]]},"reference":[{"key":"BF7700556_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.t01-3-00001.x","volume":"245","author":"KR Birikh","year":"1997","unstructured":"Birikh KR, Heaton PA, Eckstein F . The structure, function and application of the hammerhead ribozymes. Eur J Biochem. 1997;245:1\u201316.","journal-title":"Eur J Biochem."},{"key":"BF7700556_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0167-7799(98)01236-0","volume":"16","author":"B Bramlage","year":"1998","unstructured":"Bramlage B, Luzi E, Eckstein F . Designing ribozymes for the inhibition of gene expression. Trends Biotechnol. 1998;16:434\u2013438.","journal-title":"Trends Biotechnol"},{"key":"BF7700556_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0092-8674(86)90362-4","volume":"47","author":"ML Cleary","year":"1986","unstructured":"Cleary ML, Smith SD, Sklar J . Cloning and structural analysis of cDNA for bcl-2 and a hybrid bcl-2\/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986;47:19\u201328.","journal-title":"Cell."},{"key":"BF7700556_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1128\/MCB.9.2.701","volume":"9","author":"Z Chen-Levy","year":"1989","unstructured":"Chen-Levy Z, Nourse J, Cleary ML . The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol Cell Biol. 1989;9:701\u2013710.","journal-title":"Mol Cell Biol."},{"key":"BF7700556_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/335440a0","volume":"335","author":"D Vaux","year":"1988","unstructured":"Vaux D, Cory S, Adams JM . Bcl-2 gene promoters haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335:440\u2013442.","journal-title":"Nature"},{"key":"BF7700556_CR6","first-page":"9","volume":"34","author":"JC Reed","year":"1997","unstructured":"Reed JC . Bcl-2 family proteins:regulators od apoptosis and chemioresistance in hematologic malignancies. Semin Hematol. 1997;34:9\u201319.","journal-title":"Semin Hematol."},{"key":"BF7700556_CR7","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1200\/JCO.2000.18.9.1812","volume":"18","author":"JS Waters","year":"2000","unstructured":"Waters JS, Webb A, Cunningham D, et al. Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma. J Clin Oncol. 2000;18:1812\u20131823.","journal-title":"J Clin Oncol."},{"key":"BF7700556_CR8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V92.3.712","volume":"92","author":"AM Gewirtz","year":"1998","unstructured":"Gewirtz AM, Sokol DL, Ratajczak MZ . Nucleic acid therapeutic:state of the art and future prospects. Blood. 1998;92:712\u2013736.","journal-title":"Blood."},{"key":"BF7700556_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1096\/fasebj.14.1.174","volume":"14","author":"N Schiavone","year":"2000","unstructured":"Schiavone N, Rosini P, Quattrone A, et al. A conserved AU-rich element in the 3\u2032 untraslated region of bcl-2 mRNA is endowed with destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J. 2000;14:174\u2013184.","journal-title":"FASEB J."},{"key":"BF7700556_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/meth.1998.0709","volume":"17","author":"GM Wilson","year":"1999","unstructured":"Wilson GM, Brewer G . Identification and characterization of proteins binding A+U-rich elements. Methods Enzymol. 1999;17:74\u201383.","journal-title":"Methods Enzymol."},{"key":"BF7700556_CR11","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1006\/bbrc.2001.5700","volume":"287","author":"M Donnini","year":"2001","unstructured":"Donnini M, Lapucci A, Papucci L, et al. Apoptosis is associated with modifications of bcl-2 mRNA AU-binding proteins. Biochem Biophys Res Comm. 2001;287:1063\u20131069.","journal-title":"Biochem Biophys Res Comm."},{"key":"BF7700556_CR12","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1021\/bi00136a013","volume":"31","author":"J-H Yang","year":"1992","unstructured":"Yang J-H, Usman N, Chartrand P, et al. Minimum ribonucleotide requirement for catalysis by the RNA hammerhead domain. Biochemistry. 1992;31:5005\u20135009.","journal-title":"Biochemistry"},{"key":"BF7700556_CR13","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1093\/nar\/20.17.4607","volume":"20","author":"J Goodchild","year":"1992","unstructured":"Goodchild J . Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2\u2032-O-methylation. Nucleic Acids Res. 1992;20:4607\u20134612.","journal-title":"Nucleic Acids Res."},{"key":"BF7700556_CR14","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0021-9258(17)42145-4","volume":"269","author":"O Heidenreich","year":"1994","unstructured":"Heidenreich O, Benseler F, Fahrenholz A, et al. High activity and stability of hammerhead ribozymes containing 2\u2032-modified pyrimidine nucleosides and phosphorothioate. J Biol Chem. 1994;269:2131\u20132138.","journal-title":"J Biol Chem."},{"key":"BF7700556_CR15","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1093\/nar\/28.21.4059","volume":"28","author":"B Bramlage","year":"2000","unstructured":"Bramlage B, Luzi E, Eckstein F . HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition og gene expression: site selection and inhibition in cell culture. Nucleic Acids Res. 2000;28:4059\u20134067.","journal-title":"Nucleic Acids Res."},{"key":"BF7700556_CR16","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1093\/nar\/21.11.2605","volume":"21","author":"T Shimayama","year":"1993","unstructured":"Shimayama T, Nishikawa F, Nishikawa S, et al. Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages. Nucleic Acids Res. 1993;21:2605\u20132611.","journal-title":"Nucleic Acids Res."},{"key":"BF7700556_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/15257770008033050","volume":"19","author":"A Bevilacqua","year":"2000","unstructured":"Bevilacqua A, Ceriani MC, Schiavone N, et al. BCL-2 regulation targeting the AU-rich domain. Nucleosides, Nucleotides Nucleic Acids. 2000;19:1273\u20131279.","journal-title":"Nucleosides, Nucleotides Nucleic Acids."},{"key":"BF7700556_CR18","first-page":"495","volume":"80","author":"A Quattrone","year":"1995","unstructured":"Quattrone A, Papucci L, Santini V, et al. Quantitation of bcl-2 oncogene in cultured lymphoma\/leukemia cell lines and in primary leukemia b-cells by a highly sensitive RT-PCR method. Haematologica. 1995;80:495\u2013504.","journal-title":"Haematologica."},{"key":"BF7700556_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/nar\/9.1.133","volume":"9","author":"M Zuker","year":"1981","unstructured":"Zuker M, Stiegler P . Optimal computer folding of large RNA sequences using thermodynamic and auxiliary information. Nucleic Acids Res. 1981;9:133\u2013148.","journal-title":"Nucleic Acids Res."},{"key":"BF7700556_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0090-3019(00)00178-6","volume":"53","author":"T Julien","year":"2000","unstructured":"Julien T, Frankel B, Longo S, et al. Antisense-mediated inhibition of the Bcl-2 gene induces apoptosis in human malignant glioma. Surg Neurol. 2000;53:360\u2013368.","journal-title":"Surg Neurol"},{"key":"BF7700556_CR21","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(00)03207-4","volume":"356","author":"B Jansen","year":"2000","unstructured":"Jansen B, Wacheck V, Heere-Ress E, et al. Chemosensitisation of malignant melanoma by BCL2 antisense theraoy. Lancet. 2000;356:1728\u20131733.","journal-title":"Lancet"},{"key":"BF7700556_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/109153601300177583","volume":"5","author":"T Uchida","year":"2001","unstructured":"Uchida T, Gao JP, Wang C, et al. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice. Mol Urol. 2001;5:71\u201378.","journal-title":"Mol Urol."},{"key":"BF7700556_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0093-7754(01)90158-7","volume":"28","author":"AW Tolcher","year":"2001","unstructured":"Tolcher AW . Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer. Semin Oncol. 2001;28:67\u201370.","journal-title":"Semin Oncol."},{"key":"BF7700556_CR24","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1182\/blood.V95.12.3929","volume":"95","author":"M Konopleva","year":"2000","unstructured":"Konopleva M, Tari AM, Estrov Z, et al. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins. Blood. 2000;95:3929\u20133938.","journal-title":"Blood"},{"key":"BF7700556_CR25","first-page":"213","volume":"6","author":"S Gibson","year":"2000","unstructured":"Gibson S, Pellenz C, Hutchison RE, et al. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector. Clin Cancer Res. 2000;6:213\u2013222.","journal-title":"Clin Cancer Res."},{"key":"BF7700556_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1385\/MB:15:2:105","volume":"15","author":"PM Potter","year":"2000","unstructured":"Potter PM, McKenzie PP, Hussain N, et al. Construction of adenovirus for high level expression of small RNAs in mammalian cells. Mol Biotechnol. 2000;15:105\u2013114.","journal-title":"Mol Biotechnol"},{"key":"BF7700556_CR27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<846::AID-IJC13>3.0.CO;2-C","volume":"82","author":"T Dorai","year":"1999","unstructured":"Dorai T, Perlman H, Walsh K, et al. A recombinant defective adenoviralagent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2 expressing human prostate cancer cells. Int J Cancer. 1999;82:846\u2013852.","journal-title":"Int J Cancer"},{"key":"BF7700556_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/(SICI)1097-0045(19970901)32:4<246::AID-PROS4>3.0.CO;2-H","volume":"32","author":"T Dorai","year":"1997","unstructured":"Dorai T, Olson CA, Katz AE, et al. Development of a hammerhead ribozyme against bcl-2I. Preliminary evalutation of a potential gene therapeutic agent for hormone-refractory human prostate cancer. Prostate. 1997;32:246\u2013258.","journal-title":"Prostate"},{"key":"BF7700556_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002770050375","volume":"76","author":"S Scheid","year":"1998","unstructured":"Scheid S, Heinzinger M, Waller CF, et al. Bcl-2 mRNA-targeted ribozymes:effects on programmed cell death in chronic myelogenous leukemia cell lines. Ann Hematol. 1998;76:117\u2013125.","journal-title":"Ann Hematol"},{"key":"BF7700556_CR30","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(96)11103-X","volume":"349","author":"A Webb","year":"1997","unstructured":"Webb A, Cunningham D, Cother F, et al. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet. 1997;349:1137\u20131141.","journal-title":"Lancet."},{"key":"BF7700556_CR31","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1074\/jbc.M009848200","volume":"276","author":"GM Wilson","year":"2001","unstructured":"Wilson GM, Sutphen K, Chuang K, et al. Folding of A+U-rich RNA elements modulates AUF1 binding. J Biol Chem. 2001;276:8695\u20138704.","journal-title":"J Biol Chem."}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700556","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T13:54:42Z","timestamp":1647957282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"alternative-id":["BF7700556"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700556","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]},"assertion":[{"value":"10 October 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2003","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}